Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Fast Forward

Evangelicals And Israelis Team Up For Medicinal Weed

Evangelical Christians are collaborating with Israelis to launch a line of medicinal cannabis products.

Zytecur, a US-based company owned by Evangelicals, is teaming up with bio-tech companies in Israel to develop a product line that will “alleviate numerous health concerns, including epilepsy and cancer, available immediately online,” according to a press release.

“God led me to enter the medical cannabis market, conquer it, and use the proceeds to build the Kingdom of Christ,” said Chris Clark, a founder of Zytecur.

The products were developed using research by IlanBio Cultures, an American-Israeli operated corporation with headquarters in Hollister, California, and Tel Aviv. Among other ailments the products aim to treat is post-traumatic stress disorder.

Clark and his partners in Zytecur are all “followers of Christ, as well as U.S. Marine Corps combat veterans who served in the Special Operations in the Iraq war,” a press release from the company read.

Email Sam Kestenbaum at kestenbaum@forward.com

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you move on, I wanted to ask you to support the Forward’s award-winning journalism during our High Holiday Monthly Donor Drive.

If you’ve turned to the Forward in the past 12 months to better understand the world around you, we hope you will support us with a gift now. Your support has a direct impact, giving us the resources we need to report from Israel and around the U.S., across college campuses, and wherever there is news of importance to American Jews.

Make a monthly or one-time gift and support Jewish journalism throughout 5785. The first six months of your monthly gift will be matched for twice the investment in independent Jewish journalism. 

—  Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version